Rocket Pharmaceuticals (RCKT) Retained Earnings (2014 - 2026)
Rocket Pharmaceuticals (RCKT) reported Retained Earnings of -$112000.0 for Q1 2026, down 100.01% on a YoY basis from $1.7 billion in Q1 2025, and down 261.29% sequentially from -$31000.0 in Q4 2025.
Rocket Pharmaceuticals (RCKT) Retained Earnings (2014 - 2026) Analysis & Trends
Rocket Pharmaceuticals (RCKT) has 13 years of Retained Earnings data on file, last reported at -$112000.0 in Q1 2026.
- For the quarter ending Q1 2026, Retained Earnings fell 100.01% year-over-year to -$112000.0; the trailing twelve-month figure through Mar 2026 stood at -$112000.0 (down 100.01% YoY), and the FY2025 full-year result was -$31000.0, down 146.97% from the prior year.
- Retained Earnings eased to -$112000.0 in Q1 2026, from -$31000.0 in the prior quarter.
- In the past five years, Retained Earnings ranged from a high of $1.7 billion in Q1 2025 to a low of -$1.2 billion in Q3 2024.
- A 5-year average of $210.6 million and a median of -$107000.0 in 2025 frame the typical range for Retained Earnings.
- Peak annual rise in Retained Earnings reached 1624716.67% in 2024, while the deepest fall reached 180.38% in 2024.
- Tracing RCKT's Retained Earnings over 5 years: stood at -$713.8 million in 2022, then surged by 303.25% to $1.5 billion in 2023, then plunged by 100.0% to $66000.0 in 2024, then tumbled by 146.97% to -$31000.0 in 2025, then sank by 261.29% to -$112000.0 in 2026.
- Business Quant data shows RCKT's Retained Earnings at -$112000.0 in Q1 2026, -$31000.0 in Q4 2025, and -$9000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Retained Earnings (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -527.87 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | -27.89 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 12.91 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 115.82 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 14.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 11.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -622,000.00 |
| 10 | Rocket Pharmaceuticals | 357.93 Mn | 357.93 Mn | - | -112,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -112,000.00 |
| Dec 31, 2025 | -31,000.00 |
| Sep 30, 2025 | -9,000.00 |
| Jun 30, 2025 | -107,000.00 |
| Mar 31, 2025 | 1.69 Bn |
| Dec 31, 2024 | 66,000.00 |
| Sep 30, 2024 | -1.16 Bn |
| Jun 30, 2024 | -218,000.00 |
| Mar 31, 2024 | 1.46 Bn |
| Dec 31, 2023 | 1.45 Bn |
| Sep 30, 2023 | 1.44 Bn |
| Jun 30, 2023 | -722,000.00 |
| Mar 31, 2023 | -90,000.00 |
| Dec 31, 2022 | -713.78 Mn |
| Sep 30, 2022 | -596,000.00 |
| Jun 30, 2022 | -589.30 Mn |
| Mar 31, 2022 | -629,000.00 |
| Dec 31, 2021 | -491.91 Mn |
| Sep 30, 2021 | -447.70 Mn |
| Jun 30, 2021 | -397.55 Mn |